flavoxate has been researched along with Obesity in 1 studies
Flavoxate: A drug that has been used in various urinary syndromes and as an antispasmodic. Its therapeutic usefulness and its mechanism of action are not clear. It may have local anesthetic activity and direct relaxing effects on smooth muscle as well as some activity as a muscarinic antagonist.
flavoxate : A carboxylic ester resulting from the formal condensation of 3-methylflavone-8-carboxylic acid with 2-(1-piperidinyl)ethanol.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiodini, G | 1 |
| Elicio, N | 1 |
| Bertolini, S | 1 |
| Valice, S | 1 |
| Reggiani, E | 1 |
| Innocenti-Ducci, L | 1 |
1 review available for flavoxate and Obesity
| Article | Year |
|---|---|
[Effects of chronic inhibition of adipocyte phosphodiesterase on lipolysis induced with noradrenaline in normal and obese subjects].
Topics: Adipose Tissue; Adult; Blood Glucose; Fatty Acids, Nonesterified; Female; Flavonoids; Flavoxate; Gly | 1978 |